The Biotech Industry Must Tell Its Story To The Public

Scientific discovery takes long periods of trial and error. When you uncover enough new rules that work, you have a scientific revolution. Every time a big change like this happens in science, we have a fancy word for it: a new paradigm. Every day we are discovering new rules for biotechnology. Sometimes we explore down a dead end; other times, we uncover a new mystery. This is the nature of scientific discovery; it can't be rushed. Look what happened in the Aesop fable about the tortoise and

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Dan Eramian Scientific discovery takes long periods of trial and error. When you uncover enough new rules that work, you have a scientific revolution. Every time a big change like this happens in science, we have a fancy word for it: a new paradigm.

Every day we are discovering new rules for biotechnology. Sometimes we explore down a dead end; other times, we uncover a new mystery. This is the nature of scientific discovery; it can't be rushed. Look what happened in the Aesop fable about the tortoise and the hare: The tortoise prevailed because he took a slow and sure approach to running the race. Those of us in the biotechnology industry must take the tortoise's approach to establishing and publicizing our paradigm. We must clearly communicate what we are about. If we stay quiet-or if we over-reach or make boastful claims and don't deliver-we may inadvertently foster superstition, confusion, resistance ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Dan Eramian

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo